Skip to main content

Table 5 Continence of 113 patients with bladder cancer treated by TLRC versus ELRC

From: Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach

Variables

Overall (n = 113)

ELRC group (n = 48)

TLRC group (n = 65)

p value

Daytime incontinence at 12 months

 0–1 pad/day, n (%)

103 (91.2)

44 (91.7)

59 (90.8)

1a

 > 1 pad/day, n (%)

10 (8.8)

4 (8.3)

6 (9.2)

 

Nighttime incontinence at 12 months

 0–1 pad/day, n (%)

97 (85.8)

42 (87.5)

55 (84.6)

0.788a

 >1 pad/day, n (%)

16 (14.2)

6 (12.5)

10 (15.4)

 

Neobladder capacity at 12 months, mean ± SD (range), ml

397.1 ± 80.5 (360–485)

390.9 ± 77.7 (370–485)

401.7 ± 94.8 (360–470)

0.695c

  1. aPearson chi-square test
  2. bFisher exact test
  3. cIndependent t test